Evolus, Inc. (EOLS)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$5.28
+1.05%
Mkt Cap $344.82M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | $89.53M | $90.30M | +0.87% | $0.06 | $0.04 | -26.30% | — | — |
| Q4 2025 Nov 5, 2025 | $89.61M | $68.97M | -23.04% | -$0.19 | -$0.14 | +26.32% | — | — |
| Q3 2025 Aug 5, 2025 | $85.31M | $69.39M | -18.67% | -$0.09 | -$0.24 | -166.67% | — | — |
| Q2 2025 May 7, 2025 | $82.33M | $68.07M | -17.31% | -$0.10 | -$0.18 | -80.00% | — | — |
| Q1 2025 Mar 4, 2025 | $71.75M | $78.95M | +10.02% | $0.02 | $0.01 | -50.00% | — | — |
| Q4 2024 Nov 6, 2024 | $76.98M | $61.09M | -20.65% | -$0.08 | -$0.19 | -137.50% | — | — |
| Q3 2024 Jul 31, 2024 | $63.07M | $66.91M | +6.09% | -$0.06 | -$0.07 | -23.09% | — | — |
| Q2 2024 May 7, 2024 | $57.32M | $59.33M | +3.51% | -$0.07 | -$0.13 | -85.71% | — | — |
| Q1 2024 Mar 7, 2024 | $60.06M | $61.00M | +1.56% | -$0.07 | -$0.14 | -100.00% | — | — |
| Q4 2023 Nov 7, 2023 | $56.80M | $49.32M | -13.16% | -$0.22 | -$0.19 | +13.64% | — | — |
| Q3 2023 Aug 2, 2023 | $44.41M | $49.35M | +11.11% | -$0.22 | -$0.22 | +0.00% | — | — |
| Q2 2023 May 9, 2023 | $40.69M | $41.72M | +2.53% | -$0.13 | -$0.17 | -30.77% | — | — |
| Q1 2023 Mar 8, 2023 | $43.79M | $43.65M | -0.33% | -$0.14 | -$0.16 | -14.29% | — | — |
| Q4 2022 Nov 8, 2022 | $36.00M | $33.90M | -5.85% | -$0.27 | -$0.32 | -18.52% | — | — |
| Q3 2022 Aug 2, 2022 | $36.60M | $37.16M | +1.53% | -$0.24 | -$0.38 | -58.33% | — | — |
| Q2 2022 May 10, 2022 | $29.83M | $33.91M | +13.68% | -$0.41 | -$0.27 | +34.15% | — | — |
| Q1 2022 Mar 3, 2022 | $34.76M | $34.66M | -0.30% | -$0.20 | -$0.29 | -45.00% | — | — |
| Q4 2021 Nov 2, 2021 | $25.98M | $26.68M | +2.68% | -$0.32 | -$0.26 | +18.75% | — | — |
| Q3 2021 Aug 4, 2021 | $26.10M | $26.10M | +0.00% | -$0.24 | -$0.27 | -12.50% | — | — |
| Q2 2021 May 12, 2021 | $19.22M | $12.24M | -36.31% | -$0.50 | $0.19 | +138.00% | — | — |